How Much Did PharmID Raise?
Funding & Key Investors

PharmID has successfully secured a significant capital infusion, bringing its total cumulative financing to $1.2M. This latest major strategic investment of $150K underscores the market confidence in the company's specialized approach to medication management and controlled substance disposal. By leveraging advanced technological frameworks, the firm continues to solidify its position as a critical infrastructure provider within the healthcare sector, ensuring that institutional waste protocols meet the highest standards of safety and accountability.

What is PharmID?

PharmID
SoftwareHealthcare SoftwareManufacturing

PharmID operates at the intersection of healthcare technology and regulatory compliance, providing a sophisticated solution known as WasteWitness. The platform utilizes a proprietary combination of Raman spectroscopy and artificial intelligence to deliver rapid, high-fidelity validation of drug waste. This automated verification system is designed to mitigate the risks associated with controlled substance disposal, offering hospitals and pharmacies a robust mechanism to maintain audit trails and ensure complete waste integrity. By replacing manual, error-prone documentation with digital precision, PharmID addresses a critical pain point in clinical operations, effectively reducing liability and enhancing operational efficiency for enterprise-level healthcare providers.

How much funding has PharmID raised?

PharmID has raised a total of $1.2M across 2 funding rounds:

2017

Private Equity

$1M

2020

Debt

$150K

Private Equity (2017): $1M with participation from TreeHouse Health

Debt (2020): $150K led by PPP

Key Investors in PharmID

TreeHouse Health

A strategic investment firm focused on accelerating the growth of healthcare startups through collaborative partnerships and operational support.

PPP

Public-Private Partnership

What's next for PharmID?

With this recent influx of capital, PharmID is well-positioned to accelerate its market penetration and refine its AI-driven diagnostic capabilities. The company's strategic roadmap likely involves scaling its deployment footprint across larger hospital networks and integrating its WasteWitness technology into broader electronic health record ecosystems. As regulatory scrutiny regarding controlled substance management intensifies, PharmID's ability to provide verifiable, data-backed compliance will be a key driver of its long-term growth. Future initiatives will likely focus on expanding the diagnostic range of its spectroscopy hardware and enhancing the predictive analytics features of its software suite to provide deeper insights into medication disposal patterns.

See full PharmID company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Software industry

Financial SoftwareSoftwareBusiness ServicesSoftware TestingMobile App Development
Security SoftwareSoftware
Financial SoftwareSoftwareContent & Collaboration Software
Security SoftwareSoftware

Frequently Asked Questions Regarding PharmID Financial Insights

What are the most recent funding rounds that PharmID has completed, and what were the funding rounds?
PharmID has recently completed 2 funding rounds: Debt on Apr 15, 2020, Private Equity on Sep 21, 2017.
What is the total amount of funding PharmID has raised to date?
PharmID has raised a total of $1.2M in funding to date.
How many funding rounds has PharmID completed?
PharmID has completed 2 funding rounds.
How much funding did PharmID raise in its most recent funding round?
PharmID raised $150K in its most recent funding round.
Who are the lead investors in PharmID's latest funding round?
The lead investor in PharmID's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in PharmID's history?
The largest funding round in PharmID's history was $1M.
See more information about PharmID